𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Expression of mutantJAGGED1alleles in patients with Alagille syndrome

✍ Scribed by Julie Boyer; Cécile Crosnier; Catherine Driancourt; Nicole Raynaud; Marie Gonzales; Michelle Hadchouel; Michèle Meunier-Rotival


Publisher
Springer
Year
2005
Tongue
English
Weight
442 KB
Volume
116
Category
Article
ISSN
0340-6717

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Mutation analysis of Jagged1 (JAG1) in A
✍ Raymond P. Colliton; Lynn Bason; Feng-Min Lu; David A. Piccoli; Ian D. Krantz; N 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 21 KB 👁 2 views

Alagille syndrome (AGS) is an autosomal dominant disorder caused by mutations in Jagged1 (JAG1), a ligand in the evolutionarily conserved Notch signaling pathway. Previous studies have demonstrated that a wide spectrum of JAG1 mutations result in AGS. These include total gene deletions, protein trun

Identification of 36 novel Jagged1 (JAG1
✍ Albrecht Röpke; Annegret Kujat; Mechthild Gräber; Joannis Giannakudis; Ingo Hans 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 37 KB 👁 1 views

Alagille syndrome (AGS) is an autosomal dominant disorder characterized by five major symptoms: cholestasis, vertebral deformity, heart malformations, ocular defects and peculiar facial appearance. The previously described Jagged1 (JAG1) gene on chromosome 20p12 has been identified as being responsi

Fifteen novel mutations in the JAGGED1 g
✍ Cécile Crosnier; Catherine Driancourt; Nicole Raynaud; Michelle Hadchouel; Michè 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 23 KB 👁 2 views

Mutations in the human JAGGED1 gene cause Alagille syndrome, an autosomal dominant developmental disorder. The gene encodes a transmembrane protein which is a ligand of Notch receptors. We report 23 mutations in previously undescribed probands, including 15 novel mutations and 8 recurrent mutations.

Increasing the mutation rate for jagged1
✍ David L. Suskind; Karen F. Murray 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 1 views

Alagille syndrome (AGS) is caused by heterozygous mutations in JAG1, and mutations have been previously reported in about 70% of patients who meet clinical diagnostic criteria. We studied a cohort of 247 clinically well-defined patients, and using an aggressive and sequential screening approach we i